Ingredion

Ingredion's Q3 2026 operating income falls 36% in U.S./Canada amid Argo facility disruption while $3.5B Tate & Lyle acquisition reshapes the company's financial risk profile.

The Argo facility thermal event is the dominant operational story of 2026 for Ingredion, driving F&II–U.S./Canada segment operating income down 44% year-to-date and compressing group gross margin to 23% from 26%. The pending all-cash acquisition of Tate & Lyle at approximately $3.5 billion introduces a structurally different risk profile: post-close consolidated indebtedness could reach $6.0 billion versus $1.8 billion today, with integration complexity, covenant compliance, and foreign exchange hedging losses — $42 million year-to-date — already weighing on current earnings. Excluding the divested Pakistan business, underlying revenue grew 2% in Q3 2026, with volume gains in F&II–LATAM and T&HS providing the only organic bright spots.

Ingredion is a leading global ingredient solutions provider that transforms grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. The company develops, produces and sells primarily starches and sweeteners to customers across more than 60 industries worldwide. Its three reportable segments are Texture & Healthful Solutions, Food & Industrial Ingredients–LATAM, and Food & Industrial Ingredients–U.S./Canada.

Primary products

• modified and native starches
• clean-label texturizers
• hydrocolloids
• customized formulations
• glucose syrups
• high maltose syrups

“The starch and sweetener industry in the U.S. and Canada is highly competitive, and competition within these markets is largely based on product functionality, price and quality.” Competitive position, as stated in the filing